Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Latest News

Susan M. Domchek, MD
Increased Germline Testing Rates Promote Crucial Breast Cancer Care

March 8th 2023

Susan M. Domchek, MD, highlights key points related to her presentation on germline testing and breast cancer treatment.

BET Inhibitors in Cancer Therapy: © vitanovski -
BET Inhibitors in Cancer Therapy: Finding the Right Combination

March 8th 2023

Andrew Ip, MD
Liquid Biopsies and NGS Stand to Revolutionize Hematologic Malignancies

February 24th 2023

Shubham Pant, MD, MBBS
Erdafitinib Data in FGFR+ Cholangiocarcinoma Indicates Utility of NGS in Treatment Selection

February 20th 2023

Emma L. Barber, MD
Biomarkers Clarify Treatment Decisions and Sequencing in Endometrial Cancer

February 9th 2023

Video Series
Video Interviews

More News